Aequus Pharmaceuticals Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported revenue was CAD 0.346494 million compared to CAD 0.651516 million a year ago. Net loss was CAD 0.77211 million compared to CAD 0.479041 million a year ago. Basic loss per share from continuing operations was CAD 0.01.
For the six months, revenue was CAD 0.648774 million compared to CAD 1.14 million a year ago. Net loss was CAD 1.69 million compared to CAD 1.1 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago.